InsiderClue
← All stocks

GLOBUS MEDICAL INC

GMED Scheduled selling only
CIK 0001237831 #875 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$17.54M
$1.38M on a plan · $16.16M straight out of an exercise
Sold at will
$0.00
0 of 14 sales
Net
−$17.54M
$0.00 against sales at will

By person

11 insiders · 16 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
ZARRILLI STEPHEN T
Director
—
$4.28M (2) scheduled
−$4.28M
0
0.0000%
$0.00
—
Davidar David D
Director
—
$4.17M (2) scheduled
−$4.17M
673,642
0.5017%
$50.24M
−12.8%
Huller Kelly
EVP, GC, Corporate Secretary
—
$3.44M (3) scheduled
−$3.44M
0
0.0000%
$0.00
—
TOBIN JAMES R
Director
—
$2.24M (1) scheduled
−$2.24M
0
0.0000%
$0.00
—
Kline Kyle
Senior Vice President, CFO
—
$2.03M (2) scheduled
−$2.03M
0
0.0000%
$0.00
—
RHOADS ANN D
Director
—
$818.00K (2) scheduled
−$818.00K
40,384
0.0301%
$3.01M
−5.8%
Norwalk Leslie V
Director
—
$557.60K (2) scheduled
−$557.60K
10,419
0.0078%
$777.08K
−36.5%
Paul David C
Executive Chairman
—
—
—
60,417
0.0450%
$4.51M
—
Pfeil Keith W
President, CEO
—
—
—
0
0.0000%
$0.00
—
Lemaitre Dan
Director
—
—
—
0
0.0000%
$0.00
—
Scavilla Daniel T
President, CEO
—
—
—
0
0.0000%
$0.00
—

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
TOBIN JAMES R
15 Sep 2026
Director
Sold after exercise
30,000
$74.58
$2.24M
ZARRILLI STEPHEN T
18 Aug 2026
Director
Sold after exercise
25,000
$87.04
$2.18M
Davidar David D
5 Jun 2026
Director
Sold after exercise
25,000
$80.76
$2.02M
RHOADS ANN D
4 Jun 2026
Director
Exercised, kept
25,000
$26.27
$656.75K
Huller Kelly
25 Feb 2026
EVP, GC, Corporate Secretary
Sold after exercise
20,000
$94.50
$1.89M
Huller Kelly
12 Feb 2026
EVP, GC, Corporate Secretary
Sold after exercise
10,000
$87.67
$876.70K
Norwalk Leslie V
8 Jan 2026
Director
Sold on a plan
2,000
$101.10
$202.20K
Kline Kyle
8 Jan 2026
Senior Vice President, CFO
Sold after exercise
3,594
$101.10
$363.35K
Norwalk Leslie V
12 Dec 2025
Director
Sold on a plan
4,000
$88.85
$355.40K
Paul David C
8 Dec 2025
Executive Chairman
Exercised, kept
34,375
$25.52
$877.25K
Kline Kyle
1 Dec 2025
Senior Vice President, CFO
Sold after exercise
18,542
$90.00
$1.67M
Huller Kelly
25 Nov 2025
SVP, GC, Corporate Secretary
Sold after exercise
7,500
$90.00
$675.00K
Davidar David D
12 Nov 2025
Director
Sold after exercise
25,000
$86.00
$2.15M
ZARRILLI STEPHEN T
11 Nov 2025
Director
Sold after exercise
25,000
$84.29
$2.11M
RHOADS ANN D
10 Nov 2025
Director
Sold on a plan
2,000
$85.00
$170.00K
RHOADS ANN D
7 Nov 2025
Director
Sold on a plan
8,000
$81.00
$648.00K

What was left out

Form 4 filings counted 30
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 10
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 251,511
History held since 1 Feb 2017